HIV-associated sensory neuropathies
暂无分享,去创建一个
Justin C McArthur | Ahmet Hoke | J. McArthur | A. Hoke | S. Keswani | C. Cherry | C. Pardo | Carlos A Pardo | Sanjay C Keswani | Catherine L Cherry | Sanjay C. Keswani
[1] D. Katzenstein,et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels , 2002, AIDS.
[2] K. Anderson,et al. Toxicity of Antiviral Nucleoside Analogs and the Human Mitochondrial DNA Polymerase* , 2001, The Journal of Biological Chemistry.
[3] William Lewis,et al. Combined Antiretroviral Therapy Causes Cardiomyopathy and Elevates Plasma Lactate in Transgenic AIDS Mice , 2001, Laboratory Investigation.
[4] M. Dalakas,et al. Mitochondrial Alterations with Mitochondrial DNA Depletion in the Nerves of AIDS Patients with Peripheral Neuropathy Induced by 2′3′-Dideoxycytidine (ddC) , 2001, Laboratory Investigation.
[5] D. Katzenstein,et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy , 2001, Neurology.
[6] C. Pardo,et al. Human immunodeficiency virus and the peripheral nervous system workshop. , 2001, Archives of neurology.
[7] R J Miller,et al. Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.
[8] Kenneth A. Johnson,et al. Insights into the Molecular Mechanism of Mitochondrial Toxicity by AIDS Drugs* , 2001, The Journal of Biological Chemistry.
[9] J. Sagen,et al. Peripheral nerve exposure to HIV viral envelope protein gp120 induces neuropathic pain and spinal gliosis , 2001, Journal of Neuroimmunology.
[10] James N. Campbell,et al. Early Onset of Spontaneous Activity in Uninjured C-Fiber Nociceptors after Injury to Neighboring Nerve Fibers , 2001, The Journal of Neuroscience.
[11] L. Sorkin,et al. Upregulation of Dorsal Root Ganglion α2δ Calcium Channel Subunit and Its Correlation with Allodynia in Spinal Nerve-Injured Rats , 2001, The Journal of Neuroscience.
[12] A. Verma. Epidemiology and clinical features of HIV‐1 associated neuropathies , 2001, Journal of the peripheral nervous system : JPNS.
[13] M. Dalakas. Peripheral neuropathy and antiretroviral drugs , 2001, Journal of the peripheral nervous system : JPNS.
[14] J W Griffin,et al. HIV neuropathy: Insights in the pathology of HIV peripheral nerve disease , 2001, Journal of the peripheral nervous system : JPNS.
[15] J. Becker,et al. HIV-associated neurologic disease incidence changes: , 2001, Neurology.
[16] F. Maggiolo,et al. Gabapentin in painful HIV‐related neuropathy: a report of 19 patients, preliminary observations , 2001, European journal of neurology.
[17] G. Moyle. Toxicity of Antiretroviral Nucleoside and Nucleotide Analogues , 2000, Drug safety.
[18] D. Simpson,et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome (AIDS)–related Burkitt's lymphoma , 2000, Muscle & nerve.
[19] H. Manji. Neuropathy in HIV infection , 2000, Current opinion in neurology.
[20] A. Telenti,et al. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection , 2000, AIDS.
[21] O. Nascimento,et al. Distal sensory polyneuropathy in a cohort of HIV-infected children over five years of age. , 2000, Pediatrics.
[22] L. Wilkins. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.
[23] T. Hassanein,et al. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] A. Sönnerborg,et al. Antiretroviral therapy may improve sensory function in HIV-infected patients , 2000, Neurology.
[25] D. Simpson,et al. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy , 2000, Neurology.
[26] T. Kakuda,et al. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. , 2000, Clinical therapeutics.
[27] S. Maier,et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120 , 2000, Brain Research.
[28] R. Meyer,et al. Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers , 2000, Pain.
[29] D. Katzenstein,et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection , 2000, Neurology.
[30] V. Darley-Usmar,et al. Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells , 2000, Antimicrobial Agents and Chemotherapy.
[31] J. McArthur,et al. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea , 2000, AIDS.
[32] B. Sumegi,et al. Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. , 1999, Biochemical pharmacology.
[33] K. Conant,et al. Cerebrospinal fluid levels of MMP‐2, 7, and 9 are elevated in association with human immunodeficiency virus dementia , 1999, Annals of neurology.
[34] A. Cross,et al. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. , 1999, Journal of acquired immune deficiency syndromes.
[35] D. Simpson,et al. Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel. , 1999, AIDS.
[36] J. Arezzo,et al. Prevalence of peripheral neuropathy in injection drug users , 1999, Neurology.
[37] S. Waxman. The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons , 1999, Pain.
[38] A. Cross,et al. Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine. , 1999, Clinical therapeutics.
[39] J. Becker,et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.
[40] T. Doubell,et al. Peripheral Inflammation Facilitates Aβ Fiber-Mediated Synaptic Input to the Substantia Gelatinosa of the Adult Rat Spinal Cord , 1999, The Journal of Neuroscience.
[41] C. Kemper,et al. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[42] C. Yiannoutsos,et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection , 1998, Neurology.
[43] K. Chaloner,et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. , 1998, JAMA.
[44] P. Shapshak,et al. Morphometric analysis of the peripheral neuropathy of AIDS , 1998, Muscle & nerve.
[45] G. Nuovo,et al. Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization , 1997, Annals of neurology.
[46] K. Kieburtz,et al. HIV related vasculitic mononeuropathy multiplex: A role for IVIg? , 1997, Journal of neurology, neurosurgery, and psychiatry.
[47] G. Barlovatz-Meimon,et al. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells , 1997, Journal of the Neurological Sciences.
[48] C. Woolf,et al. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α , 1997, British journal of pharmacology.
[49] D. Valenti,et al. 3'-Azido-3'-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator. , 1997, Biochemical pharmacology.
[50] J. Sommadossi,et al. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. , 1997, The Journal of pharmacology and experimental therapeutics.
[51] J. McArthur,et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy , 1997, Neurology.
[52] A. Verma,et al. Painful vasculitic neuropathy in HIV-1 infection , 1996, Neurology.
[53] R. Myers,et al. Endoneurial injection of TNF-α produces neuropathic pain behaviors , 1996 .
[54] R. Coggeshall,et al. Collateral Sprouting of Uninjured Primary Afferent A-Fibers into the Superficial Dorsal Horn of the Adult Rat Spinal Cord after Topical Capsaicin Treatment to the Sciatic Nerve , 1996, The Journal of Neuroscience.
[55] S. Ueno,et al. Prosaposin Facilitates Sciatic Nerve Regeneration In Vivo , 1996, Journal of neurochemistry.
[56] G. D. Dal Pan,et al. Low-dose zalcitabine-related toxic neuropathy , 1996, Neurology.
[57] P. Shapshak,et al. Increased NADPH-diaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome , 1996, Journal of the Neurological Sciences.
[58] J. Arezzo,et al. Didanosine (ddl) and stavudine (d4T): absence of peripheral neurotoxicity in rabbits. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[59] C. Fichtenbaum,et al. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[60] S. Wesselingh,et al. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[61] S. Keilbaugh,et al. Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation. , 1995, Biochemical pharmacology.
[62] M. Tagliati,et al. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[63] M. Dalakas,et al. Mitochondrial toxicity of antiviral drugs , 1995, Nature Medicine.
[64] C. Chalk,et al. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease , 1994, Journal of virology.
[65] S. Keilbaugh,et al. Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase. , 1994, Biochemical pharmacology.
[66] J. Becker,et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. , 1994, Neurology.
[67] P. Shapshak,et al. Expression of HIV‐1 and interleukin‐6 in lumbosacral dorsal root ganglia of patients with AIDS , 1994, Neurology.
[68] Y. So,et al. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: Experience in 23 patients , 1994, Annals of neurology.
[69] J. Modica-Napolitano. AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. , 1993, Biochemical and biophysical research communications.
[70] C. Lamotte,et al. Deafferentation‐induced terminal field expansion of myelinated saphenous afferents in the adult rat dorsal horn and the nucleus gracilis following pronase injection of the sciatic nerve , 1993, The Journal of comparative neurology.
[71] J C Arezzo,et al. 2',3'‐Dideoxycytidine (ddC) toxic neuropathy , 1993, Neurology.
[72] G. Gronseth,et al. Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. , 1993, Archives of neurology.
[73] L. Thal,et al. Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. , 1992, Archives of neurology.
[74] J. Hauw,et al. Lymphoma-induced polyradiculopathy in AIDS: Two cases , 1992, Journal of Neurology.
[75] C. H. Chen,et al. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.
[76] C. Lacroix,et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study , 1991, Annals of neurology.
[77] D. Holtzman,et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. , 1988, Archives of neurology.
[78] D. Lanska,et al. Syphilitic polyradiculopathy in an HIV‐positive man , 1988, Neurology.
[79] D. Cornblath,et al. Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex , 1988, Neurology.
[80] R. Schooley,et al. Peripheral neuropathy in the acquired immunodeficiency syndrome , 1988, Annals of neurology.
[81] D. Price,et al. Gracile tract degeneration in patients with sensory neuropathy and AIDS , 1988, Neurology.
[82] J. Griffin,et al. Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection , 1987, Annals of neurology.
[83] C. Crumpacker,et al. Progressive polyradiculopathy in acquired immune deficiency syndrome , 1986, Neurology.
[84] G. Zanette,et al. Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy , 2004, Acta Neuropathologica.
[85] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.
[86] S. Shott,et al. Topical capsaicin in the management of HIV-associated peripheral neuropathy. , 2000, Journal of pain and symptom management.
[87] Joakim Bjorkdahl. Prevalence of peripheral neuropathy in injection drug users. , 2000 .
[88] S. Kaul,et al. Toxicokinetics of 2',3'-didehydro-3'-deoxythymidine, stavudine (D4T). , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[89] M. Tagliati,et al. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. , 1999, Archives of neurology.
[90] D. Spelman,et al. An analysis of factors associated with HIV-related peripheral neuropathy , 1997 .
[91] R. Myers,et al. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. , 1996, Neuroreport.
[92] L. Caniatti,et al. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. , 1996, Journal of the peripheral nervous system : JPNS.
[93] C. Lamotte,et al. Deafferentation-induced expression of GAP-43, NCAM, and NILE in the adult rat dorsal horn following pronase injection of the sciatic nerve. , 1995, Somatosensory & motor research.
[94] S. Steinberg,et al. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. , 1993, The Journal of infectious diseases.
[95] T. Anderson,et al. Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[96] H. Schaumburg,et al. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[97] J. Gastaut,et al. [Peripheral neuropathies in human immunodeficiency virus infection. A prospective study of 56 patients]. , 1989, Revue neurologique.